8:00am-10:00am

PLENARY SESSION 7 - Tumor Microenvironment - Session Chair - Marisol Soengas
Pentland Suite

Click here to view this recording.

8:00am - 8:20am

Deciphering molecular patterns of resistance to immune checkpoint blockade in melanoma

Presented by: Göran Jönsson

8:20am - 8:35am

The spatial landscape of progression and immunoediting in primary melanoma at single cell resolution
Presented by: Zoltan Maliga

8:35am - 8:50am

Apolipoprotein E2 enhances melanoma progression and pro-tumorigenic protein synthesis
Presented by: Nneoma Adaku

8:50am - 9:10am

MIDKINE drives immune evasion by rewiring dendritic cell differentiation and immunogenicity
Presented by: Xavier Catena

9:10am - 9:25am

Dissecting the cellular and molecular interaction networks that promote melanoma stemness at the perivascular niche
Presented by: Ada Nowosad

9:25am - 9:40am

Stromal lipid species dictate melanoma metastasis and tropism
Presented by: Shilpa Gurung

9:40am - 10:00am

Coming of age: how age impacts tumor progression
Presented by: Ashi Weeraratna

10:00am - 10:20am

Refreshment Break
Cromdale Hall & Strathblane Hall

10:20am - 11:05am

Keynote Presentation by David Fisher
Pentland Hall

Click here to view this recording.

11:05am - 12:45pm

PLENARY SESSION 8 - New Therapies and Clinical Trials - Session Chair - Caroline Robert
Pentland Suite

Click here to view this recording.

11:05am - 11:25am

Results from the randomized controlled phase 3 trial in PD-1 blockade refractory melanoma comparing ipilimumab to TIL therapy

Presented by: John Haanen

11:25am - 11:45am

Trials to reduce toxicity of checkpoint inhibition
Presented by: Jeff Weber

11:45am - 12:00pm

Clinical trials in oncology: what remains and what changes?

Presented by: Everardo Saad

12:00pm - 12:15pm

How to best address the actual medical needs?

Presented by: Dirk Schadendorf

12:15pm - 12:45pm

Q&A/ Panel Discussion
Presented by: John Haanen, Everado Saad, Mike Davies, Alex Menzies, Dirk Schadendorf and Caroline Robert

12:45pm - 1:00pm

Closing Remarks by Liz Patton & Mike Davies
Pentland Hall